Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study
Background There are concerns that the response to the COVID-19 pandemic in the UK
might have worsened physical and mental health, and reduced use of health services …
might have worsened physical and mental health, and reduced use of health services …
The impact of varying the number and selection of conditions on estimated multimorbidity prevalence: a cross-sectional study using a large, primary care population …
Background Multimorbidity prevalence rates vary considerably depending on the conditions
considered in the morbidity count, but there is no standardised approach to the number or …
considered in the morbidity count, but there is no standardised approach to the number or …
[HTML][HTML] Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals
Background Large-scale and contemporary population-based studies of heart failure
incidence are needed to inform resource planning and research prioritisation but current …
incidence are needed to inform resource planning and research prioritisation but current …
Hospitalisation and mortality in patients with comorbid COPD and heart failure: a systematic review and meta-analysis
EL Axson, K Ragutheeswaran, V Sundaram… - Respiratory …, 2020 - Springer
Background Discrepancy exists amongst studies investigating the effect of comorbid heart
failure (HF) on the morbidity and mortality of chronic obstructive pulmonary disease (COPD) …
failure (HF) on the morbidity and mortality of chronic obstructive pulmonary disease (COPD) …
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort …
Background Early descriptions of patients admitted to hospital during the COVID-19
pandemic showed a lower prevalence of asthma and chronic obstructive pulmonary disease …
pandemic showed a lower prevalence of asthma and chronic obstructive pulmonary disease …
Frequency and severity of exacerbations of COPD associated with future risk of exacerbations and mortality: a UK routine health care data study
H Whittaker, A Rubino, H Müllerová… - … Journal of Chronic …, 2022 - Taylor & Francis
Background Studies have shown that chronic obstructive pulmonary disease (COPD)
exacerbation events are related to future events; however, previous literature typically …
exacerbation events are related to future events; however, previous literature typically …
Natural history of chronic obstructive pulmonary disease exacerbations in a general practice–based population with chronic obstructive pulmonary disease
Rationale: Acute exacerbations of chronic obstructive pulmonary disease (AECOPDs) are
important adverse events in the natural history of chronic obstructive pulmonary disease …
important adverse events in the natural history of chronic obstructive pulmonary disease …
[HTML][HTML] A comparison of the ability of the National Early Warning Score and the National Early Warning Score 2 to identify patients at risk of in-hospital mortality: A …
Aims To compare the ability of the National Early Warning Score (NEWS) and the National
Early Warning Score 2 (NEWS2) to identify patients at risk of in-hospital mortality and other …
Early Warning Score 2 (NEWS2) to identify patients at risk of in-hospital mortality and other …
Asthma-Related Health Outcomes Associated with Short-Acting β2-Agonist Inhaler Use: An Observational UK Study as Part of the SABINA Global Program
CI Bloom, C Cabrera, S Arnetorp, K Coulton, C Nan… - Advances in …, 2020 - Springer
Introduction Patients with asthma typically increase short-acting β 2-agonists (SABA) use
with worsening symptoms. Excessive SABA use may lead to a higher risk of adverse …
with worsening symptoms. Excessive SABA use may lead to a higher risk of adverse …
Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based …
Objective To determine whether the use of glucagon-like peptide 1 (GLP-1) receptor
agonists, dipeptidyl peptidase 4 (DPP-4) inhibitors, and sodium-glucose co-transporter-2 …
agonists, dipeptidyl peptidase 4 (DPP-4) inhibitors, and sodium-glucose co-transporter-2 …